Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase 1 combination study of the CHK1 inhibitor prexasertib (LY2606368) and anti-PD-L1 antibody LY3300054, in patients with high-grade serous ovarian cancer and other advanced solid tumors

Khanh Do,Claire Manuszak,Sarah Kelland,Allison Powers,Adrienne Anderson,Alona Muzikansky,Andrew Wolanski,Mariano Severgnini,Geoffrey Shapiro

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）

Cited 0|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined